Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
about
Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.Squamous Cell Cancers: A Unified Perspective on Biology and GeneticsBMP signaling and its paradoxical effects in tumorigenesis and dissemination.The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation.The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A.VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors.Cancer Stem Cells in Squamous Cell Carcinoma.Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and CancerThe Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane.Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells.Sulforaphane reduces YAP/∆Np63α signaling to reduce cancer stem cell survival and tumor formation.Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation
P2860
Q33728989-3EE5BCBA-60CB-4098-A131-EA91BB457AE6Q33914216-2FAC6C95-3916-4A67-B6DF-AA51D17ED968Q36545265-6367CFC0-2404-433A-902F-EF4FCF810E74Q36909843-5CE10232-FC54-4D29-8092-C7F16FD72E75Q37718513-C0B36A81-E8B3-4680-B2CC-13B8ED9A12FFQ38706007-D008B076-A4F7-4E59-9358-8F07AF9D4B78Q38736793-B61736A0-A079-4FDF-95AB-DD27BF320526Q38792331-787117E3-288D-40A1-926C-A2946C28DAA3Q38800006-0F9398B7-C939-40A6-9BE3-F0C9F2831E1EQ38957139-D11959C6-EB29-4A01-847C-62939CD639B3Q38993869-B3CCC2E2-D724-431C-AE41-334C3242025EQ39454240-429E14AB-91B3-4578-B9F8-1BB635B34AFAQ41841298-43EF8239-E6B8-41B5-BC2F-077E5FFB8DA3Q47117055-614AD7D6-60B0-41E6-9E26-DD2812DE3B19Q47158107-5047D232-51C7-4B11-9517-5886F6C697EDQ50954236-213F587A-1552-4546-BDE9-51D87D5A7508Q57818345-31528EAE-75A5-4877-AD19-44B7B3E16F7F
P2860
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
@ast
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
@en
type
label
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
@ast
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
@en
prefLabel
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
@ast
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
@en
P2093
P2860
P356
P1433
P1476
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein
@en
P2093
Candace Kerr
Gautam Adhikary
Jennifer M Huang
Richard L Eckert
Sivaprakasam Balasubramanian
P2860
P304
P356
10.1093/CARCIN/BGV064
P407
P50
P577
2015-05-12T00:00:00Z